Merck updates on Phase 3 Keynote-412 trial in advanced head and neck squamous cell carcinoma

Govt introduces 'Draft of New Drugs, Medical Devices and Cosmetics Bill, 2022'

The Bill aims to amend and consolidate the law relating to the import, manufacture, distribution and sale of drugs, medical devices and cosmetics

PHARMAP 2022 concludes with productive networking of pharma leaders

The Congress was held on June, 20-21, 2022 in Berlin, Germany

Menarini Group and Radius Health submit new drug application to the USFDA for Elacestrant

Intended for potential treatment of ER+/HER2- advanced or metastatic breast cancer patients

Cadila Pharma launches formulation development lab

The ground floor of the formulation development laboratory is focused on solid orals, the first floor on injections, and the second floor houses the analytical lab

FDA accepts application for Merck’s Keytruda as adjuvant therapy for Stage IB-IIIA lung cancer

Acceptance based on results from the phase 3 KEYNOTE-091 trial

DFE Pharma opens its new Center of Excellence in Hyderabad, India

The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs

NHA announces revamped ABHA mobile application

The revamped Ayushman Bharat Health Account (ABHA) mobile application offers added functionalities and a new User Interface (UI)

Govt. launches single national portal for biotech researchers and start-ups

The Portal BioRRAP will cater to all those seeking regulatory approval for biological research

Piramal Pharma Solutions new API plant in Canada goes online

It is part of the company's CAD $30 million capital investment in the Aurora, Canada site